Centre for Cancer Cell & Molecular Biology

Our main mission within the Centre is to elucidate the fundamental mechanisms of cancer cell biology and how these can be therapeutically targeted. Our central aim is to understand the basic biology of cancer cells and harness this knowledge to identify new treatment strategies.

Cells massage their nucleus to repair DNA, revealing a possible cancer vulnerability

Cells soften and massage their nucleus to encourage the repair of broken DNA, research led by Professor Susana Godinho and team has discovered. Using cells grown in the laboratory, the researchers uncovered a previously unknown role for movement within cells in DNA repair. Their findings could point towards new ways to make cancer cells more sensitive to existing treatments that damage DNA or disrupt its repair.

Publications   28 October 2026

A stylised 3D illustration of a purple RNA strand curving across a blurred purple and blue molecular background.

Protein lost in lung cancer reveals hidden layer of gene control

Scientists at Barts Cancer Institute, Queen Mary University of London, have uncovered an important way that cells keep their genes under control. The discovery could help explain one of the earliest molecular changes that occurs during the development of lung cancer. The study, published in Science Advances, reveals that a protein called LIMD1, which is frequently lost in lung cancer, plays a much bigger role in controlling gene activity than scientists previously realised. The findings uncover a previously hidden layer of gene regulation and may provide new insight into how normal cells begin to lose control during the earliest stages of cancer.

Publications   23 July 2026

Gloved hand holding a blood sample in a purple-capped tube with racks of test tubes in a clinical lab setting.

AI combines multiple DNA clues to improve cancer detection from blood

Researchers have developed an artificial intelligence method that can detect signs of cancer by combining several different clues found in DNA fragments circulating in the blood. The method, developed by a team led by scientists at Barts Cancer Institute, Queen Mary University of London, and the University of Cambridge, uses a comparatively inexpensive form of genome sequencing to detect signals shared by a range of cancer types.

Publications   10 July 2026

Scientists awarded £5.7m to harness epigenetics in next-generation anti-viral therapies

BCI researcher Dr Gabriella Ficz and team have been awarded funding as part of a £5.7m national collaborative initiative exploring how epigenetics can be harnessed to strengthen our immune system’s ability to fight viruses. Dr Ficz will receive £880,000 to support her team’s contribution to the epiPRIME project, awarded by the Advanced Research and Invention Agency (ARIA).

Grants & Awards   25 June 2026

New Epigenetics Hub set to advance early disease detection

A £3m collaboration will investigate how marks on DNA in blood enable early disease detection

General News   29 January 2024

How cancer cells shapeshift to spread through the body

A new study from Professor Susana Godinho and team has shed light on one way that cancer cells rearrange their inner workings to squeeze their way between obstacles – shapeshifting to escape their original tissue and travel through the body.

General News   23 August 2023

Investigating new strategies to target lung cancer

Recent research from Barts Cancer Institute (BCI) at Queen Mary University of London has identified a novel therapeutic strategy to target lung cancer tumours that lack the gene LIMD1.

General News   6 December 2021

Understanding centrosome amplification in cancer

Dr Susana Godinho, Group Leader in the Centre for Cancer Cell & Molecular Biology at Barts Cancer Institute, Queen Mary University of London, has recently received a Cancer Research UK Discovery Programme Foundation Award. The award of approximately £1.4 million over 6 years will support a research project that will investigate the impact of centrosome amplification in cancer.

General News   12 July 2021

Long noncoding RNAs in genome stability and cancer

Dr Lovorka Stojic, Group Leader in the Centre for Cancer Cell & Molecular Biology at Barts Cancer Institute, Queen Mary University of London, has recently received a Cancer Research UK Career Establishment Award to investigate the role of long noncoding RNAs in the maintenance of genome stability and in cancer.

General News   16 April 2021

Cancer cell communications

We spoke with Dr Susana Godinho, Group Leader in Barts Cancer Institute’s Centre for Cancer Cell and Molecular Biology, to find out about her recent paper published in Current Biology. Dr Godinho and her team set out to identify why cancer cells carrying extra centrosomes exhibit increased release of communications packages known as small extracellular vesicles.

Interviews   12 March 2021

Breaking down the barrier

The Medical Research Council has awarded Dr Godinho a £600,000 project grant to fund vital research on pancreatic cancer, that will investigate ways to tackle the impenetrable barrier that surrounds pancreatic tumours, in the hope of identifying targets for therapeutic intervention.

General News   22 October 2019

‘The neighbouring effect’: Centrosomal abnormalities drive invasion of surrounding cells

Centrosomal amplification, a particular change that occurs within some cancer cells, has been shown to drive the invasion of neighbouring cancer cells.

General News   19 November 2018